Reuters logo
BRIEF-Neuren's Phase 2 trial of trofinetide demonstrates significant clinical benefit in pediatric rett syndrome
March 25, 2017 / 1:35 AM / 9 months ago

BRIEF-Neuren's Phase 2 trial of trofinetide demonstrates significant clinical benefit in pediatric rett syndrome

March 24 (Reuters) - Neuren Pharmaceuticals

* Neuren’s Phase 2 trial of trofinetide demonstrates significant clinical benefit in pediatric rett syndrome Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below